Merck said adjusted earnings for the three months ending in December were pegged at $1.16 per share, up 11.5% from the same period last year and one penny ahead of the Street consensus forecast.
More Merck Tops Q4 Profit Forecast, Plans Womens’ Health, Biosimlars Spinoff Videos